← Back to companies
Pipeline Therapeutics
42+ employees
Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Contineum targets biological pathways associated with specific clinical disabilities, that once modulated, can demonstrably impact the course of disease.
Open Positions at Pipeline Therapeutics (0 Jobs)
Ready to start your space career at Pipeline Therapeutics?
